Literature DB >> 12440558

Diagnostic approach to the patient with diffuse lung disease.

Jay H Ryu1, Eric J Olson, David E Midthun, Stephen J Swensen.   

Abstract

Detecting diffuse lung infiltrates on chest radiography is a common clinical problem. Many diverse pathological processes can cause diffuse lung disease. The presentation of these diseases can vary from acute to chronic and includes a side array of radiological patterns that are optimally evaluated on high-resolution computed tomography of the chest. In diagnosing diffuse lung disease, it is helpful to focus on a few pivotal parameters to narrow the broad differential diagnosis. We describe the diagnostic approach to a patient with diffuse lung disease usingthe following key parameters: tempo of the pathological process, characteristics of the radiological pattern, and clinical context.

Entities:  

Mesh:

Year:  2002        PMID: 12440558     DOI: 10.4065/77.11.1221

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  9 in total

1.  The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease.

Authors:  Harry Karmouty-Quintana; Hongyan Zhong; Luis Acero; Tingting Weng; Ernestina Melicoff; James D West; Anna Hemnes; Almut Grenz; Holger K Eltzschig; Timothy S Blackwell; Yang Xia; Richard A Johnston; Dewan Zeng; Luiz Belardinelli; Michael R Blackburn
Journal:  FASEB J       Date:  2012-03-13       Impact factor: 5.191

2.  Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors.

Authors:  Masahiro Tsuboi; Thierry Le Chevalier
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

3.  The diagnostic yield and complications of open lung biopsies in kidney transplant patients with pulmonary disease.

Authors:  Daniere Yurie Vieira Tomotani; Antônio Tonete Bafi; Eduardo Souza Pacheco; Tainá Veras de Sandes-Freitas; Laila Almeida Viana; Edgar Porto de Oliveira Pontes; Nikkei Tamura; Hélio Tedesco-Silva; Flavia Ribeiro Machado; Flávio Geraldo Rezende Freitas
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

4.  Dyspnea in palliative care: expanding the role of corticosteroids.

Authors:  Richard J Lin; Ronald D Adelman; Sonal S Mehta
Journal:  J Palliat Med       Date:  2012-03-02       Impact factor: 2.947

5.  Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle.

Authors:  Eric B Meltzer; William T Barry; Thomas A D'Amico; Robert D Davis; Shu S Lin; Mark W Onaitis; Lake D Morrison; Thomas A Sporn; Mark P Steele; Paul W Noble
Journal:  BMC Med Genomics       Date:  2011-10-05       Impact factor: 3.063

6.  A young non-immunocompromised woman with diffuse alveolar opacities.

Authors:  Prem Parkash Gupta; Manish Verma; Dipti Agarwal; Sanjay Kumar; Atulya Atreja
Journal:  Lung India       Date:  2010-10

7.  Influence of autoimmune biomarkers on interstitial lung diseases: A tertiary referral center based case-control study.

Authors:  Philippe R Bauer; Sanjay Kalra; Thomas G Osborn; Jennifer St Sauver; Andrew C Hanson; Darrell R Schroeder; Jay H Ryu
Journal:  Respir Med       Date:  2015-01-31       Impact factor: 3.415

8.  Utility of Radial Probe Endobronchial Ultrasound-Guided Transbronchial Lung Biopsy in Diffuse Lung Lesions.

Authors:  Eun Jin Kim; Kyung Chan Kim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2019-05-31

9.  Transbronchial cryobiopsy validity in diagnosing diffuse parenchymal lung diseases in Egyptian population.

Authors:  Hanaa Shafiek; Shaimaa Elbialy; Samar Nabil El Achy; Ahmed Youssef Shaaban Gad
Journal:  J Multidiscip Healthc       Date:  2019-08-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.